Oleh Hornykiewicz - Publications

University of Vienna, Wien, Wien, Austria 
Dopamine, Parkinson's Disease

210 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain : a Journal of Neurology. 140: 2460-2474. PMID 29050386 DOI: 10.1093/brain/awx172  0.6
2017 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. The European Journal of Neuroscience. 45: 1356. PMID 28523903 DOI: 10.1111/ejn.13573  1
2016 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/ejn.13435  1
2016 Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology. PMID 27488599 DOI: 10.1212/WNL.0000000000003065  1
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiology of Disease. 82: 243-253. PMID 26102022 DOI: 10.1016/j.nbd.2015.06.010  0.6
2015 Hornykiewicz O. 50 years of levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1008. PMID 25999218 DOI: 10.1002/mds.26240  1
2015 Pifl C, Reither H, Hornykiewicz O. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. European Journal of Pharmacology. 755: 119-26. PMID 25771452 DOI: 10.1016/j.ejphar.2015.03.004  1
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: Relationship to α-synuclein accumulation Neurobiology of Disease. 82: 243-253. DOI: 10.1016/j.nbd.2015.06.010  1
2014 Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8210-8. PMID 24920625 DOI: 10.1523/JNEUROSCI.5456-13.2014  1
2013 Pifl C, Hornykiewicz O, Blesa J, Adánez R, Cavada C, Obeso JA. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism. Journal of Neurochemistry. 125: 657-62. PMID 23331162 DOI: 10.1111/jnc.12162  1
2012 Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/mds.25109  1
2012 Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiology of Disease. 48: 79-91. PMID 22677034 DOI: 10.1016/j.nbd.2012.05.018  1
2011 Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience. 180: 280-92. PMID 21333719 DOI: 10.1016/j.neuroscience.2011.02.017  1
2011 Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ. Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiology of Disease. 41: 458-68. PMID 21029775 DOI: 10.1016/j.nbd.2010.10.017  1
2011 Ouattara B, Grégoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T. Metabotropic glutamate receptor type 5 in levodopa-induced motor complications. Neurobiology of Aging. 32: 1286-95. PMID 20036444 DOI: 10.1016/j.neurobiolaging.2009.07.014  1
2010 Hornykiewicz O. A brief history of levodopa. Journal of Neurology. 257: S249-52. PMID 21080185 DOI: 10.1007/s00415-010-5741-y  1
2010 Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain : a Journal of Neurology. 133: 172-88. PMID 19903734 DOI: 10.1093/brain/awp282  1
2009 Samadi P, Rajput A, Calon F, Grégoire L, Hornykiewicz O, Rajput AH, Di Paolo T. Metabotropic glutamate receptor II in the brains of Parkinsonian patients. Journal of Neuropathology and Experimental Neurology. 68: 374-82. PMID 19287314 DOI: 10.1097/NEN.0b013e31819cabe4  1
2009 Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/brain/awn337  1
2008 Hornykiewicz O. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neuro-Degenerative Diseases. 5: 114-7. PMID 18322366 DOI: 10.1159/000113678  1
2008 Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology. 70: 1403-10. PMID 18172064 DOI: 10.1212/01.wnl.0000285082.18969.3a  1
2008 Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain : a Journal of Neurology. 131: 120-31. PMID 17956909 DOI: 10.1093/brain/awm239  1
2007 Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. Journal of Neurochemistry. 102: 1691-702. PMID 17484728 DOI: 10.1111/j.1471-4159.2007.04636.x  1
2006 Tong J, Hornykiewicz O, Kish SJ. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology. 63: 1724-8. PMID 17172611 DOI: 10.1001/archneur.63.12.1724  1
2006 Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. Journal of Neural Transmission. Supplementum. 9-15. PMID 17017502  1
2006 Pifl C, Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochemistry International. 49: 519-24. PMID 16698121 DOI: 10.1016/j.neuint.2006.03.013  1
2006 Tong J, Hornykiewicz O, Kish SJ. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. Journal of Neurochemistry. 96: 349-54. PMID 16336226 DOI: 10.1111/j.1471-4159.2005.03546.x  1
2005 Woldman I, Reither H, Kattinger A, Hornykiewicz O, Pifl C. Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology. 48: 525-37. PMID 15755480 DOI: 10.1016/j.neuropharm.2004.11.013  1
2004 Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, et al. Levodopa in the treatment of Parkinson's disease: current controversies. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 997-1005. PMID 15372588 DOI: 10.1002/mds.20243  0.4
2004 Yamamoto K, Hornykiewicz O. Proposal for a noradrenaline hypothesis of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 913-22. PMID 15363614 DOI: 10.1016/j.pnpbp.2004.05.033  1
2004 Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proceedings of the National Academy of Sciences of the United States of America. 101: 9843-8. PMID 15210960 DOI: 10.1073/pnas.0403495101  1
2004 Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O. Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism & Related Disorders. 10: 221-6. PMID 15120096 DOI: 10.1016/j.parkreldis.2004.01.004  1
2004 Calon F, Dridi M, Hornykiewicz O, Bédard PJ, Rajput AH, Di Paolo T. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain : a Journal of Neurology. 127: 1075-84. PMID 15033896 DOI: 10.1093/brain/awh128  1
2004 Pifl C, Khorchide M, Kattinger A, Reither H, Hardy J, Hornykiewicz O. alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. Neuroscience Letters. 354: 34-7. PMID 14698476 DOI: 10.1016/j.neulet.2003.09.064  1
2003 Calon F, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiology of Disease. 14: 404-16. PMID 14678757 DOI: 10.1016/j.nbd.2003.07.003  1
2003 Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry. 87: 574-85. PMID 14535941 DOI: 10.1046/j.1471-4159.2003.02017.x  0.6
2003 Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 241-53. PMID 12621627 DOI: 10.1002/mds.10343  1
2002 Hornykiewicz O. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids. 23: 65-70. PMID 12373520 DOI: 10.1007/s00726-001-0111-9  1
2002 Pifl C, Kattinger A, Reither H, Hornykiewicz O. Cellular effects of dopamine--beyond oxidative mechanisms. Parkinsonism & Related Disorders. 8: 433-7. PMID 12217632 DOI: 10.1016/S1353-8020(02)00028-7  1
2002 Hornykiewicz O. Dopamine miracle: from brain homogenate to dopamine replacement. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 501-8. PMID 12112197 DOI: 10.1002/mds.10115  1
2002 Rajput AH, Fenton ME, Birdi S, Macaulay R, George D, Rozdilsky B, Ang LC, Senthilselvan A, Hornykiewicz O. Clinical-pathological study of levodopa complications. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 289-96. PMID 11921114 DOI: 10.1002/mds.10031  1
2002 Calon F, Birdi S, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias. Journal of Neuropathology and Experimental Neurology. 61: 186-96. PMID 11853020  1
2001 Birkmayer W, Hornykiewicz O. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wiener Klinische Wochenschrift. 113: 851-4. PMID 11763859  1
2001 Hornykiewicz O. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago. Wiener Klinische Wochenschrift. 113: 855-62. PMID 11762121  1
2001 Tekumalla PK, Calon F, Rahman Z, Birdi S, Rajput AH, Hornykiewicz O, Di Paolo T, Bédard PJ, Nestler EJ. Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biological Psychiatry. 50: 813-6. PMID 11720701 DOI: 10.1016/S0006-3223(01)01234-3  1
2001 Hornykiewicz O. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Advances in Neurology. 86: 1-11. PMID 11553966  1
2001 Hornykiewicz O. Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease. Journal of Chemical Neuroanatomy. 22: 3-12. PMID 11470551 DOI: 10.1016/S0891-0618(01)00100-4  1
2001 Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1607-9. PMID 11427501  1
2000 Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299  1
1999 Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263  1
1998 Birkmayer W, Hornykiewicz O. The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism & Related Disorders. 4: 59-60. PMID 18591089 DOI: 10.1016/S1353-8020(98)00013-3  1
1998 Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism & Related Disorders. 4: 53-7. PMID 18591088 DOI: 10.1016/S1353-8020(98)00012-1  1
1998 Furukawa Y, Shimadzu M, Hornykiewicz O, Kish SJ. Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia. Advances in Neurology. 78: 267-82. PMID 9750923  1
1998 Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology. 51: S2-9. PMID 9711973  1
1998 Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM, Snow BJ, Calne DB. Hereditary form of parkinsonism--dementia. Annals of Neurology. 43: 768-81. PMID 9629847 DOI: 10.1002/ana.410430612  1
1998 Furukawa Y, Lang AE, Trugman JM, Bird TD, Hunter A, Sadeh M, Tagawa T, St George-Hyslop PH, Guttman M, Morris LW, Hornykiewicz O, Shimadzu M, Kish SJ. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology. 50: 1015-20. PMID 9566388  1
1996 Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470  1
1996 Pifl C, Hornykiewicz O, Giros B, Caron MG. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 277: 1437-43. PMID 8667208  1
1996 Furukawa Y, Shimadzu M, Rajput AH, Shimizu Y, Tagawa T, Mori H, Yokochi M, Narabayashi H, Hornykiewicz O, Mizuno Y, Kish SJ. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Annals of Neurology. 39: 609-17. PMID 8619546 DOI: 10.1002/ana.410390510  1
1996 Hornykiewicz O. Neurotransmitters in Parkinson's disease | NEUROTRANSMITTER BEI PARKINSONSCHER ERKRANKUNG Tw Neurologie Psychiatrie. 10: 3.  1
1995 Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 10-7. PMID 7885342 DOI: 10.1002/mds.870100104  1
1995 Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology. 47: 368-73. PMID 7870046  1
1995 Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Annals of Neurology. 38: 260-4. PMID 7654075 DOI: 10.1002/ana.410380220  1
1994 Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Research. 639: 33-41. PMID 8180836 DOI: 10.1016/0006-8993(94)91761-2  1
1994 Baran H, Vass K, Lassmann H, Hornykiewicz O. The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Research. 646: 201-6. PMID 8069664 DOI: 10.1016/0006-8993(94)90078-7  1
1994 Hornykiewicz O, Shannak K. Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease. Journal of Neural Transmission. Supplementum. 42: 219-27. PMID 7964689  1
1994 Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, Hornykiewicz O. Dopa-responsive dystonia: pathological and biochemical observations in a case. Annals of Neurology. 35: 396-402. PMID 7908789 DOI: 10.1002/ana.410350405  1
1993 Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Advances in Neurology. 60: 140-7. PMID 8420131  1
1993 Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Journal of Neurochemistry. 61: 890-8. PMID 8395565  1
1993 Hörtnagl H, Berger ML, Havelec L, Hornykiewicz O. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 2939-45. PMID 7687281  1
1992 Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 642-8. PMID 1729408 DOI: 10.1111/j.1471-4159.1992.tb09766.x  1
1992 Berger ML, Veitl M, Malessa S, Sluga E, Hornykiewicz O. Cholinergic markers in ALS spinal cord. Journal of the Neurological Sciences. 108: 114-7. PMID 1624947 DOI: 10.1016/0022-510X(92)90196-R  1
1992 Pifl C, Reither H, Hornykiewicz O. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat. Brain Research. 572: 87-93. PMID 1535275 DOI: 10.1016/0006-8993(92)90455-I  1
1992 Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O. Brain neurotransmitter changes in human narcolepsy. Neurology. 42: 229-34. PMID 1370862  1
1992 Pifl C, Schingnitz G, Hornykiewicz O. Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: the symptomatic versus the asymptomatic condition. Neurochemistry International. 20: 295S-297S. PMID 1365445 DOI: 10.1016/0197-0186(92)90255-P  1
1992 Pifl C, Nanoff C, Schingnitz G, Schütz W, Hornykiewicz O. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 1997-2004. PMID 1349341  1
1992 Hornykiewicz O. Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective. Clinical Neurology and Neurosurgery. 94: S9-11. PMID 1320533 DOI: 10.1016/0303-8467(92)90008-Q  1
1991 Suess E, Malessa S, Ungersböck K, Kitz P, Podreka I, Heimberger K, Hornykiewicz O, Deecke L. Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 32: 1675-81. PMID 1880567  1
1991 Pifl C, Reither H, Hornykiewicz O. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. European Journal of Pharmacology. 202: 273-6. PMID 1839386 DOI: 10.1016/0014-2999(91)90304-9  1
1991 Warsh JJ, Politsky JM, Li PP, Kish SJ, Hornykiewicz O. Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease. Journal of Neurochemistry. 56: 1417-22. PMID 1825844  1
1991 Kish SJ, Du F, Parks DA, Robitaille Y, Ball MJ, Schut L, Hornykiewicz O, Schwarcz R. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 29: 100-4. PMID 1825460 DOI: 10.1002/ana.410290119  1
1991 Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience. 44: 591-605. PMID 1754053 DOI: 10.1016/0306-4522(91)90080-8  1
1991 Young LT, Warsh JJ, Li PP, Siu KP, Becker L, Gilbert J, Hornykiewicz O, Kish SJ. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Brain Research. Developmental Brain Research. 61: 243-8. PMID 1752042 DOI: 10.1016/0165-3806(91)90137-8  1
1991 Bertel O, Malessa S, Sluga E, Hornykiewicz O. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Research. 566: 54-60. PMID 1726065 DOI: 10.1016/0006-8993(91)91680-Y  1
1991 Malessa S, Leigh PN, Bertel O, Sluga E, Hornykiewicz O. Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 984-8. PMID 1686899  1
1991 Hörtnagl H, Berger ML, Reither H, Hornykiewicz O. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: effect on glutamatergic systems. Naunyn-Schmiedeberg's Archives of Pharmacology. 344: 213-9. PMID 1682822 DOI: 10.1007/BF00167221  1
1991 Peele R, Seymour JG, Robins AH, White DAC, Kish S, Hornykiewicz O, Slimovitch C, Kleinert R, Maurer E, Minauf M, Walter GF, Gilbert J, Rezvani A, Myers R. Fatal hyperthermia syndrome [14] American Journal of Psychiatry. 148: 1411-1412. PMID 1680297  1
1990 Pifl C, Bertel O, Schingnitz G, Hornykiewicz O. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochemistry International. 17: 263-70. PMID 20504626 DOI: 10.1016/0197-0186(90)90148-M  1
1990 Riley DE, Lang AE, Lewis A, Resch L, Ashby P, Hornykiewicz O, Black S. Cortical-basal ganglionic degeneration. Neurology. 40: 1203-12. PMID 2381527  1
1990 Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O. [3H]vesamicol binding in human brain cholinergic deficiency disorders. Neuroscience Letters. 117: 347-52. PMID 2151294 DOI: 10.1016/0304-3940(90)90689-7  1
1990 Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, Maurer E, Rezvani Y, Myers R, Hornykiewicz O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. The American Journal of Psychiatry. 147: 1358-63. PMID 2133042  1
1990 Seitelberger F, Lassmann H, Hornykiewicz O. Some mechanisms of brain edema studied in a kainic acid model. Acta Neurobiologiae Experimentalis. 50: 263-7. PMID 2130648  1
1989 Baran H, Hörtnagl H, Hornykiewicz O. Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine. Brain Research. 495: 253-60. PMID 2765930 DOI: 10.1016/0006-8993(89)90219-9  1
1989 Berger ML, Lassmann H, Hornykiewicz O. Limbic seizures without brain damage after injection of low doses of kainic acid into the amygdala of freely moving rats. Brain Research. 489: 261-72. PMID 2743156 DOI: 10.1016/0006-8993(89)90859-7  1
1989 Hornykiewicz O. Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 319-28. PMID 2664888 DOI: 10.1016/0278-5846(89)90121-8  1
1989 Kish S, Karlinsky H, Becker L, Gilbert J, Rebbetoy M, Chang LJ, DiStefano L, Hornykiewicz O. Down's syndrome individuals begin life with normal levels of brain cholinergic markers. Journal of Neurochemistry. 52: 1183-7. PMID 2522539  1
1988 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine. 318: 876-80. PMID 3352672 DOI: 10.1056/NEJM198804073181402  1
1988 Hornykiewicz O. Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities. The Mount Sinai Journal of Medicine, New York. 55: 11-20. PMID 3279301  1
1988 Wagner HN, Weinberger DR, Kleinman JE, Casanova MF, Gibbs CJ, Gur RE, Hornykiewicz O, Kuhar MJ, Pettegrew JW, Seeman P. Neuroimaging and neuropathology. Schizophrenia Bulletin. 14: 383-97. PMID 3264934  1
1988 Pifl C, Schingnitz G, Hornykiewicz O. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Neuroscience Letters. 92: 228-33. PMID 3263594 DOI: 10.1016/0304-3940(88)90066-3  1
1988 Pifl C, Hornykiewicz O. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. European Journal of Pharmacology. 146: 189-91. PMID 3258244 DOI: 10.1016/0014-2999(88)90504-3  1
1988 Hornykiewicz O. The pathochemical perspectives of Parkinson's disease. An attempt at a neurochemical definition. Functional Neurology. 3: 379-91. PMID 3072274  1
1988 Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology. 24: 688-91. PMID 2904794 DOI: 10.1002/ana.410240518  1
1988 Guiloff RJ, Emami JM, During M, Freese A, Plaitakis A, Mandeli J, Smith J, Yahr M, Shashidharan P, Malessa S, Leigh N, Hornykiewicz O. BRANCHED-CHAIN AMINOACIDS IN AMYOTROPHIC LATERAL SCLEROSIS The Lancet. 332: 680-682. PMID 2901533 DOI: 10.1016/S0140-6736(88)90488-6  1
1988 Pifl C, Pichler L, Kobinger W, Hornykiewicz O. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. European Journal of Pharmacology. 153: 33-44. PMID 2463928 DOI: 10.1016/0014-2999(88)90585-7  1
1988 Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans). Advances in Neurology. 50: 157-65. PMID 2456673  1
1987 Kish S, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. GABA-dopamine relationship in Parkinson's disease striatum. Advances in Neurology. 45: 75-7. PMID 3825737  1
1987 Baran H, Lassmann H, Sperk G, Seitelberger F, Hornykiewicz O. Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neuroscience. 21: 679-84. PMID 3114666 DOI: 10.1016/0306-4522(87)90029-7  1
1987 Pichler L, Pifl C, Hornykiewicz O, Kobinger W. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats. European Journal of Pharmacology. 135: 239-42. PMID 2884121 DOI: 10.1016/0014-2999(87)90618-2  1
1987 Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Advances in Neurology. 45: 19-34. PMID 2881444  1
1987 Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Annals of Neurology. 22: 386-9. PMID 2445259 DOI: 10.1002/ana.410220318  1
1986 Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. European Journal of Pharmacology. 131: 75-86. PMID 3816949 DOI: 10.1016/0014-2999(86)90517-0  1
1986 Lassmann H, Baran H, Petsche U, Kitz K, Sperk G, Hornykiewicz O, Seitelberger F. Ultrastructural analysis of rat brain tissue following systemic kainate administration. Advances in Experimental Medicine and Biology. 203: 223-30. PMID 3788706  1
1986 Hornykiewicz O. Brain noradrenaline and schizophrenia. Progress in Brain Research. 65: 29-39. PMID 3538161 DOI: 10.1016/S0079-6123(08)60639-1  1
1986 Kish SJ, Morito CL, Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochemical Pathology. 4: 23-8. PMID 2940481 DOI: 10.1007/BF02834296  1
1986 Kish SJ, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Annals of Neurology. 20: 26-31. PMID 2874765 DOI: 10.1002/ana.410200106  1
1986 Seizinger BR, Liebisch DC, Kish SJ, Arendt RM, Hornykiewicz O, Herz A. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system. Brain Research. 378: 405-8. PMID 2873872 DOI: 10.1016/0006-8993(86)90946-7  1
1986 Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans. The New England Journal of Medicine. 315: 347-53. PMID 2426591 DOI: 10.1056/NEJM198608073150602  1
1985 Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neuroscience Letters. 58: 343-6. PMID 4047494 DOI: 10.1016/0304-3940(85)90078-3  1
1985 Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O. Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Research. 338: 289-95. PMID 4027598 DOI: 10.1016/0008-8749(85)90067-X  1
1985 Kish SJ, Perry TL, Sweeney VP, Hornykiewicz O. Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy. Neuroscience Letters. 58: 241-4. PMID 2995877 DOI: 10.1016/0304-3940(85)90171-5  1
1985 Baran H, Sperk G, Hörtnagl H, Sapetschnig G, Hornykiewicz O. Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures. European Journal of Pharmacology. 113: 263-9. PMID 2995067 DOI: 10.1016/0014-2999(85)90744-7  1
1985 Kish SJ, Fox IH, Kapur BM, Lloyd K, Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome. Brain Research. 336: 117-23. PMID 2988699 DOI: 10.1016/0006-8993(85)90422-6  1
1985 Hornykiewicz O. [The life history of brain dopamine]. Wiener Klinische Wochenschrift. 97: 350-4. PMID 2986364  1
1985 Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Annals of Neurology. 18: 530-6. PMID 2416269 DOI: 10.1002/ana.410180504  1
1985 Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Annals of Neurology. 17: 405-7. PMID 2408557 DOI: 10.1002/ana.410170419  1
1985 Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O. Kainic acid-induced seizures: Dose-relationship of behavioural neurochemical and histopathological changes Brain Research. 338: 289-295. DOI: 10.1016/0006-8993(85)90159-3  1
1984 Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology. 41: 612-4. PMID 6721735 DOI: 10.1001/archneur.1984.04210080020007  1
1984 Kish SJ, Shannak KS, Hornykiewicz O. Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 1476-8. PMID 6707646  1
1984 Lassmann H, Petsche U, Kitz K, Baran H, Sperk G, Seitelberger F, Hornykiewicz O. The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neuroscience. 13: 691-704. PMID 6527775 DOI: 10.1016/0306-4522(84)90089-7  1
1984 Kish SJ, Perry TL, Hornykiewicz O. Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 466-9. PMID 6319600 DOI: 10.1111/j.1471-4159.1984.tb02700.x  1
1984 Hörtnagl H, Pichler L, Holzer-Petsche U, Hornykiewicz O, Kobinger W. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain. European Journal of Pharmacology. 106: 335-44. PMID 6152218 DOI: 10.1016/0014-2999(84)90721-0  1
1984 Hornykiewicz O, Kish SJ. Neurochemical basis of dementia in Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 185-90. PMID 6143610  1
1983 Hörtnagl H, Schlögl E, Sperk G, Hornykiewicz O. The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain. Progress in Brain Research. 58: 269-74. PMID 6635192 DOI: 10.1016/S0079-6123(08)60029-1  1
1983 Kish SJ, Sperk G, Hornykiewicz O. Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid. Neuropharmacology. 22: 1303-9. PMID 6320037 DOI: 10.1016/0028-3908(83)90204-6  1
1983 Kish SJ, Perry TL, Hornykiewicz O. Increased GABA receptor binding in dominantly-inherited cerebellar ataxias. Brain Research. 269: 370-3. PMID 6309324 DOI: 10.1016/0006-8993(83)90149-X  1
1983 Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10: 1301-15. PMID 6141539 DOI: 10.1016/0306-4522(83)90113-6  1
1983 Kish SJ, Shannak KS, Perry TL, Hornykiewicz O. Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum. Journal of Neurochemistry. 41: 1495-7. PMID 6137518 DOI: 10.1111/j.1471-4159.1983.tb00852.x  1
1982 Hornykiewicz O. Imbalance of brain monoamines and clinical disorders. Progress in Brain Research. 55: 419-29. PMID 7163495 DOI: 10.1016/S0079-6123(08)64212-0  1
1982 Hornykiewicz O. Brain catecholamines in schizophrenia -- a good case for noradrenaline. Nature. 299: 484-6. PMID 7121591 DOI: 10.1038/299484a0  1
1982 Berger M, Sperk G, Hornykiewicz O. Serotonergic denervation partially protects rat striatum from kainic acid toxicity. Nature. 299: 254-6. PMID 6213866  1
1982 Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lee T, Seeman P. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Archives of Neurology. 39: 644-6. PMID 6127066 DOI: 10.1001/archneur.1982.00510220042009  1
1981 van der Kooy D, Hattori T, Shannak K, Hornykiewicz O. The pallido-subthalamic projection in rat: anatomical and biochemical studies. Brain Research. 204: 253-68. PMID 7459631 DOI: 10.1016/0006-8993(81)90587-4  1
1981 Sperk G, Hörtnagl H, Reither H, Hornykiewicz O. Evidence for neuronal localization of histamine-N-methyltransferase in rat brain. Journal of Neurochemistry. 37: 525-6. PMID 7264677  1
1981 Lee T, Seeman P, Hornykiewicz O, Bilbao J, Deck J, Tourtellotte WW. Parkinson's disease: low density and presynaptic location of D3 dopamine receptors. Brain Research. 212: 494-8. PMID 7225883 DOI: 10.1016/0006-8993(81)90484-4  1
1981 Higatsberger MR, Sperk G, Bernheimer H, Shannak KS, Hornykiewicz O. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease. Experimental Brain Research. 44: 93-6. PMID 6456150 DOI: 10.1007/BF00238752  1
1981 Sperk G, Hörtnagl H, Reither H, Hornykiewicz O. Changes in histamine in the rat striatum following local injection of kainic acid. Neuroscience. 6: 2669-75. PMID 6275301 DOI: 10.1016/0306-4522(81)90111-1  1
1981 Sperk G, Berger M, Hörtnagl H, Hornykiewicz O. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. European Journal of Pharmacology. 74: 279-86. PMID 6170518 DOI: 10.1016/0014-2999(81)90046-7  1
1981 Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. The New England Journal of Medicine. 305: 1106-11. PMID 6117011 DOI: 10.1056/NEJM198111053051902  1
1981 Hornykiewicz O. Parkinson syndrome and antiparkinson agents | PARKINSON-SYNDROM UND ANTIPARKINSONMITTEL Deutsche Apotheker Zeitung. 121: 225-227.  1
1981 Sperk G, Berger M, Hornykiewicz O. Influence of kainic acid lesions on turnover of dopamine and serotonin in the striatum Naunyn-Schmiedeberg's Archives of Pharmacology. 316: 264.  1
1980 Hornykiewicz O. [Brain dopamine and brain disorders - and what we have learned from these studies (author's transl)]. Wiener Klinische Wochenschrift. 92: 740-3. PMID 7467350  1
1980 Sperk G, Galhaup I, Shlögl E, Hörtnagl H, Hornykiewicz O. A sensitive and reliable assay for dopamine beta-hydroxylase in tissue. Journal of Neurochemistry. 35: 972-6. PMID 7452299  1
1980 Lloyd KG, Hockmann CH, Davidson L, Farley IJ, Hornykiewicz O. Kinetics of L-DOPA metabolism in the caudate nucleus of cats with ventrotegmental lesions. Journal of Neural Transmission. Supplementum. 33-44. PMID 6933223  1
1980 Shannak KS, Hornykiewicz O. Brain monoamines in the rhesus monkey during long-term neuroleptic administration. Advances in Biochemical Psychopharmacology. 24: 315-23. PMID 6157310  1
1980 Farley IJ, Shannak KS, Hornykiewicz O. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. Advances in Biochemical Psychopharmacology. 21: 427-33. PMID 6155058  1
1980 Berger M, Hornykiewicz O. Drug effects on kainic acid lesions in the striatal region in rat Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie. 361: 268.  1
1979 Fariello RG, Hornykiewicz O. Substantia nigra and pentylenetetrazol threshold in rats: correlation with striatal dopamine metabolism. Experimental Neurology. 65: 202-8. PMID 262229 DOI: 10.1016/0014-4886(79)90260-7  1
1979 Rajput AH, Rozdilsky B, Hornykiewicz O. Susceptibility to drug-induced Parkinsonism Neurology. 29: 567.  1
1979 Hornykiewicz O. Compensatory neurotransmitter changes in the parkinsonian brain: Effect of dopaminergic drug treatment Canadian Journal of Neurological Sciences. 6: 81.  1
1978 Price KS, Farley IJ, Hornykiewicz O. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine. Advances in Biochemical Psychopharmacology. 19: 293-300. PMID 696462  1
1978 Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature. 273: 59-61. PMID 692671 DOI: 10.1038/273059a0  1
1978 Farley IJ, Price KS, McCullough E, Deck JH, Hordynski W, Hornykiewicz O. Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. Science (New York, N.Y.). 200: 456-8. PMID 644310  1
1978 Shibuya M, Fariello R, Farley IJ, Price KS, Lloyd KG, Hornykiewicz O. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum. Experimental Neurology. 58: 486-99. PMID 620704 DOI: 10.1016/0014-4886(78)90103-6  1
1978 Koffer KB, Berney S, Hornykiewicz O. The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy. European Journal of Pharmacology. 47: 81-6. PMID 338314 DOI: 10.1016/0014-2999(78)90377-1  1
1978 Hachinski V, Shibuya M, Norris JW, Hornykiewicz O. Cerebrospinal fluid homovanillic acid in cerebral infarction. Journal of Neural Transmission. Supplementum. 45-50. PMID 290739  1
1978 Hornykiewicz O. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Neuroscience. 3: 773-83. PMID 30919 DOI: 10.1016/0306-4522(78)90030-1  1
1977 Lloyd KG, Hornykiewicz O. Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra Life Sciences. 21: 1489-1495. PMID 927011 DOI: 10.1016/0024-3205(77)90204-1  1
1977 Farley IJ, Price KS, Hornykiewicz O. Dopamine in thelimbic regions of the human brain: normal and abnormal. Advances in Biochemical Psychopharmacology. 16: 57-64. PMID 883559  1
1977 Iloyd KG, Shemen L, Hornykiewicz O. Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease. Brain Research. 127: 269-78. PMID 861759 DOI: 10.1016/0006-8993(77)90540-6  1
1977 Farley IJ, Hornykiewicz O. Noradrenaline distribution insubcortical areas of the human brain. Brain Research. 126: 53-62. PMID 851895 DOI: 10.1016/0006-8993(77)90214-1  1
1977 Berney S, Hornykiewicz O. The effect of beta-endorphin and met-enkephalin on striatin dopamine metabolism and catalepsy: comparison with morphine. Communications in Psychopharmacology. 1: 597-604. PMID 564766  1
1977 Hornykiewicz O. Historical aspects and frontiers of Parkinson's disease research. Advances in Experimental Medicine and Biology. 90: 1-20. PMID 22225  1
1977 Lloyd KG, Shibuya M, Davidson L, Hornykiewicz O. Chronic neuroleptic therapy: tolerance and GABA systems. Advances in Biochemical Psychopharmacology. 16: 409-15. PMID 18890  1
1977 Hornykiewicz O. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Annual Review of Pharmacology and Toxicology. 17: 545-59. PMID 17361 DOI: 10.1146/annurev.pa.17.040177.002553  1
1976 De Léan J, Richardson JC, Hornykiewicz O. Beneficial effects of serotonin precursors in postanoxic action myoclonus. Neurology. 26: 863-8. PMID 1084968  1
1976 Menon K, Bieger D, Hornykiewicz O. Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid. Journal of Neural Transmission. 39: 177-86. PMID 978199 DOI: 10.1007/BF01256508  1
1976 Hornykiewicz O. Neurohumoral interactions and basal ganglia function and dysfunction. Research Publications - Association For Research in Nervous and Mental Disease. 55: 269-80. PMID 12547  1
1976 Hornykiewicz O. Extrapyramidal dyskinesias and brain amine metabolism Psychopharmacology Bulletin. 12: 57.  1
1975 Hornykiewicz O. Biochemical and pharmacological basis of the clinical use of L dioxyphenylalanine in Parkinson's syndrome | BIOCHEMISCH PHARMAKOLOGISCHE GRUNDLAGEN FUR DIE KLINISCHE ANWENDUNG DES L DIOXYPHENYL ALANINS BEIM PARKINSON SYNDROM Wiener Medizinische Wochenschrift. 125: 325-327. PMID 1216856  1
1975 Hornykiewicz O. Brain monoamines and Parkinsonism. Psychopharmacology Bulletin. 11: 34-5. PMID 1153656  1
1975 Hornykiewicz O. Parkinsonism induced by dopaminergic antagonists. Advances in Neurology. 9: 155-64. PMID 1096571  1
1975 Hornykiewicz O. Brain monoamines and parkinsonism. National Institute On Drug Abuse Research Monograph Series. 13-21. PMID 787796  1
1975 Hornykiewicz O. Parkinson's disease and its chemotherapy. Biochemical Pharmacology. 24: 1061-5. PMID 239718 DOI: 10.1016/0006-2952(75)90190-2  1
1975 Fariello RG, Lloyd KG, Hornykiewicz O. Cortical and subcortical projected foci in cats: inhibitory action of taurine. Neurology. 25: 1077-83. PMID 171598  1
1975 Lloyd KG, Davidson L, Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. The Journal of Pharmacology and Experimental Therapeutics. 195: 453-64. PMID 489  1
1975 Fariello R, Hornykiewicz O. Septal and caudate influences on the activity of an acute amygdaloid epileptogenic focus Canadian Journal of Neurological Sciences. 2: 339.  1
1975 Hornykiewicz O. Abnormalities of nigrostriatal dopamine metabolism: neurochemical, morphological and clinical correlations | NEUROPSYCHOPHARMACOLOGY. PROCEEDINGS OF THE IX CONGRESS OF THE COLLEGIUM INTERNATIONALE NEUROPSYCHOPHARMACOLOGICUM, PARIS, 7-12 JULY, 1974 Excerpta Medica, Amsterdam. 524-529.  1
1974 Lloyd KG, Farley IJ, Deck JH, Hornykiewicz O. Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Advances in Biochemical Psychopharmacology. 11: 387-97. PMID 4845706  1
1974 Derkach P, Larochelle L, Bieger D, Hornykiewicz O. L-DOPA-chlorpromazine antagonism on running activity in mice. Canadian Journal of Physiology and Pharmacology. 52: 114-8. PMID 4825682  1
1974 Hornykiewicz O. The mechanisms of action of L-dopa in Parkinson's disease. Life Sciences. 15: 1249-59. PMID 4620977 DOI: 10.1016/0024-3205(74)90306-3  1
1974 Kuschinsky K, Hornykiewicz O. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice. European Journal of Pharmacology. 26: 41-50. PMID 4598755 DOI: 10.1016/0014-2999(74)90072-7  1
1974 Hornykiewicz O. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders. Journal of Psychiatric Research. 11: 249-53. PMID 4282386 DOI: 10.1016/0022-3956(74)90098-3  1
1974 Hornykiewicz O. Metabolism of dopamine and l-dopa in human brain Biochemical Pharmacology. 23: 917-923. DOI: 10.1016/0006-2952(74)90162-2  1
1974 Fariello R, Lloyd KG, Hornykiewicz O. Taurine and transmitted epileptic activity in cats Pharmacologist. 16: no.208.  1
1973 Lloyd KG, Hornykiewicz O. L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy. Nature. 243: 521-3. PMID 4743649 DOI: 10.1038/243521a0  1
1973 Sharpe JA, Rewcastle NB, Lloyd KG, Hornykiewicz O, Hill M, Tasker RR. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation. Journal of the Neurological Sciences. 19: 275-86. PMID 4716845 DOI: 10.1016/0022-510X(73)90091-9  1
1973 Hornykiewicz O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). British Medical Bulletin. 29: 172-8. PMID 4356552  1
1973 Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences. 20: 415-55. PMID 4272516 DOI: 10.1016/0022-510X(73)90175-5  1
1973 Hornykiewicz O. Parkinson's disease: from brain homogenate to treatment. Federation Proceedings. 32: 183-90. PMID 4143953  1
1973 Hornykiewicz O. Metabolism of dopamine and L dopa in the human brain Life Sciences. 13: 1xxiv-1xxvi.  1
1973 Hornykiewicz O. Metabolism of dopamine and L-dopa in the human brain Life Sciences. 13: lxxiv-lxxvi.  1
1972 Bieger D, Hornykiewicz O. Dopamine in the earthworm, Lumbricus terrestris: enhancement of rhythmic contractile activity. Neuropharmacology. 11: 745-8. PMID 4670601 DOI: 10.1016/0028-3908(72)90085-8  1
1972 Brown GM, Krigstein E, Dankova J, Hornykiewicz O. Relationship between hypothalamic and median eminence catecholamines and thyroid function. Neuroendocrinology. 10: 207-17. PMID 4653504  1
1972 Lloyd KG, Hornykiewicz O. Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. Journal of Neurochemistry. 19: 1549-59. PMID 4624686  1
1972 Bieger D, Larochelle L, Hornykiewicz O. A model for the quantitative study of central dopaminergic and serotoninergic activity. European Journal of Pharmacology. 18: 128-36. PMID 4555562 DOI: 10.1016/0014-2999(72)90140-9  1
1971 Hockman CH, Lloyd KG, Farley IJ, Hornykiewicz O. Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease. Brain Research. 35: 613-8. PMID 5135560 DOI: 10.1016/0006-8993(71)90513-0  1
1958 BORN GV, HORNYKIEWICZ O, STAFFORD A. The uptake of adrenaline and noradrenaline by blood platelets of the pig. British Journal of Pharmacology and Chemotherapy. 13: 411-4. PMID 13618545  1
1957 BORN GV, HORNYKIEWICZ O. The proportionality between the uptake of adrenaline by blood platelets and their content of adenosine triphosphate. The Journal of Physiology. 136: 30P-1P. PMID 13429505  1
1956 HORNYKIEWICZ O, KOBINGER W. [Effects of physostigmine, tetraethylpyrophosphate, and neostigmine on the blood pressure and pressor reflexes of the carotid sinus in rats]. Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 228: 493-500. PMID 13348675  0.52
Show low-probability matches.